Articles
08.09.2015
The rise of speciality products

It is the responsibility of CCGs to manage their local drug budgets

Read more
Articles
11.08.2015
EU price websites

This article contains official prices at the ex-manufacturer, wholesaler and pharmacy selling price ...

Read more
Articles
24.07.2015
Cancer Drug Fund remit

The proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...

Read more
News
21.07.2015
PMA Presentation July 2015

In this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...

Read more
Articles
20.07.2015
Innovative payment methods

Pharmaceutical companies are now launching curative treatments, in addition to drugs which only mana...

Read more
Articles
15.07.2015
The future of the Cancer Drug Fund

NHS England have recently proposed that NICE should take a more direct role in determining which pro...

Read more
News
15.06.2015
An update on UK market access at EUCOPE meeting

An update on UK market access at EUCOPE meeting

Read more
Publications
20.05.2015
ISPOR 2015 Biosimilar pricing and reimbursement

This study determines if EU pricing and reimbursement bodies have revised their pricing and reimburs...

Read more
Articles
18.05.2015
Biosimilar pricing and reimbursement pathways

European payers have not considered biosimilars to be comparable to their reference products or full...

Read more
26.03.2015
Are pharmaceutical drug prices too high in the EU?

A recent publication from the WHO identifies that EU pharmaceutical drug prices are too high and tha...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.